The Gut-Brain Axis Summit 2018

DESCRIPTION

On 06 & 07 September 2018, Paris will host the BioTech Pharma Summit: Gut-Brain Axis 2018 conference. This year’s event brings together leading scientists, physicians, and senior leaders to explore the brain and its engagement with the GI-nervous system axis in health and disease.

With 20+ expert speakers, 20+ case studies demonstrating disease causation of the gut-brain axis

The ability of gut microbiota to communicate with the brain is emerging as an exciting concept in health and disease. Mounting evidence, mostly from rodent studies, suggests that gut microbes help shape normal neural development, brain biochemistry, and behaviour.

The Gut-Brain Axis 2018 is set to be the “must-attend” meeting for anyone interested in unlocking the potential of the gut-brain axis, and translating it into safe, effective and commercially viable therapeutics.

 

The Gut-Axis 2018 will be dedicated to help large pharma, biotech, academics and clinicians exploring and understand the GBA in demonstrating disease causation.

 

 

 

 

 

 

KEY PRACTICAL LEARNING POINTS

  • Commercialisation and investment perspectives of microbiome – based diagnostics and therapeutics
  • Effectively understand and manipulate the Gut-Brain Axis
  • Learn about the microbiota and their metabolites and neurotransmitters production
  • The impact of environment and age on shaping our individual microbiota
  • Discover tools and technologies to help investigate the GBA
  • Build predictive pre-clinical models in the gut-brain axis
  • Role that the GI microbiome plays in modulating the immune system and the GI-brain axis.
  • Current options for prevention, diagnosis and treatment of neurodegenerative, metabolic and autoimmune disorders
  • The importance of the gut–brain axis in emotional, behavioral and development disorders
  • Clinical applications of microbiome in oncology and beyond
  • Develop commercially viable therapeutics and nutritional products
  • Probiotics, prebiotics, synbiotics and psychobiotics

WHO SHOULD ATTEND?

The BioTech Pharma Summit (EPM Group) are exclusive events designed for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed members of academic and government institutions. CEOs, VPs, Drug developers, Academics and Researchers, CROs, Scientists and Medical Doctors including:

  • Professors
  • Medical Immunology and Microbiology
  • Medical Advisor
  • Neuroscientist
  • Integrative & Experimental Pathology
  • Drug Discovery
  • Regulatory Affairs
  • Medicinal Chemistry & CMC
  • Associate Research Director
  • Strategy & Business
  • IVD Assay Development
  • Safety Risk Lead
  • Preclinical Group Leader
  • Pharmacovigilance
  • Medical Information Manager
  • Research Investigator
  • Physiologists
  • Scientific Project Leader
  • Head Search & Evaluation Neuroscience
  • Molecular Toxicology
  • Nutrition & Health
  • Laboratory Director
  • Modeling and Data Specialist
  • Microbiome and Lipid Biology
  • Genome Editing

Ruth Ann Luna
Ruth Ann Luna
Assistant Professor and Director at Baylor College of Medicine
Serguei Fetissov
Serguei Fetissov
Professor of physiology at Rouen University and co-founder of TargEDys
Shahram Lavasani
Shahram Lavasani
Founder and CEO at ImmuneBiotech AB
Wouter de Jonge
Professor of Neurogastroenterology at AMC, CoFounder of Gut Research
Rochellys Diaz Heijtz
Rochellys Diaz Heijtz
Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet
Birgitte Holst
Birgitte Holst
Professor MSO in Metabolic and Molecular Pharmacology
Emeran Mayer
Gastroenterologist, Neuroscientist
Bruno Bonaz
Professor of Gastroenterology
Ted Dinan
Ted Dinan
Professor of Psychiatry and a Principal Investigator in the APC Microbiome Institute
Sarkis K. Mazmanian
Co-Founder
Nikolaos Venizelos
Nikolaos Venizelos
Professor emeritus and Head of the Neuropsychiatric Research Laboratory & Biobank
Martha Welch
Martha Welch
Director
David Finkelstein
Head, Parkinson’s Disease Laboratory, Florey Institute of Neuroscience and Mental Health
Christopher Reyes
Christopher Reyes
Co-founder and CSO
Koen Venema
Founder & CEO and Chair in Gut Microbiology
Derrick MacFabe
Derrick MacFabe
Director
Robert Brummer
Robert Brummer
Professor and Director
Marion Soto
Marion Soto
Project leader
Patrice Garnier
Patrice Garnier
CEO
Philip Strandwitz
Philip Strandwitz
Co-Founder and CEO
George Weinstock
George Weinstock
Professor, Director for Microbial Genomics
Event Details
Sponsors